로딩 중…
지수 로딩 중…
OptimizeRx Corporation
OPRX· NASDAQ· Health Care· Health Care Equipment & Services
$7.29-3.95%
2026-09-18
Financials
Valuation Metrics
OptimizeRx Corporation's Market Cap is $137M. At end of 2025 it was $229M. Ranked #3058 of 3,121 in US market (top 98%), #1411 of 1,463 on NASDAQ (top 96%), #195 of 205 in Health Care Equipment & Services (top 95%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $137M | US#3,058/3,121 Sec#195/205 |
| Revenue | $99M | US#2,709/3,121 Sec#186/205 |
| Net Income | $5M | US#2,209/3,121 Sec#115/205 |
| Total Assets | $164M | US#3,023/3,121 Sec#192/205 |
| Net Assets | $131M | US#2,772/3,121 Sec#172/205 |
| Employees | 133 | US#2,577/3,121 Sec#178/205 |
| Value | ||
| P/E | 29.73x | US#1,614/3,121 Sec#63/205 |
| P/B | 1.04x | US#466/3,121 Sec#24/205 |
| P/S | 1.39x | US#1,000/3,121 Sec#66/205 |
| EV/EBITDA | 8.47x | US#629/3,121 Sec#18/205 |
| FCF Yield | 13.42% | US#361/3,121 Sec#12/205 |
| Profitability | ||
| ROE | 3.51% | US#1,924/3,121 Sec#96/205 |
| ROA | 2.80% | US#1,468/3,121 Sec#92/205 |
| Op. Margin | 11.45% | US#1,485/3,121 Sec#65/205 |
| Revenue Growth | -5.82% | US#2,513/3,121 Sec#185/205 |
| Financial Health | ||
| Debt Ratio | 25.35% | US#281/3,121 Sec#30/205 |
| Total Debt | $19M | US#2,763/3,121 Sec#173/205 |
| FCF | $18M | US#2,189/3,121 Sec#134/205 |
| Cash | $24M | US#2,825/3,121 Sec#186/205 |
| Current Ratio | 5.58x | US#422/3,121 Sec#32/205 |
| Net Debt/EBITDA | -0.30x | US#465/3,121 Sec#37/205 |
| Performance | ||
| 1Y Return | -61.47% | US#2,995/3,121 Sec#196/205 |
| 1M Return | -8.99% | US#2,168/3,121 Sec#156/205 |
| From 52W High | -67.24% | US#2,980/3,121 Sec#197/205 |
| 1Y MDD | -79.06% | US#3,060/3,121 Sec#197/205 |
| Trading | ||
| Volume | 206,859 shares | US#2,998/3,121 Sec#201/205 |
| Trading Value | $2M | US#3,067/3,121 Sec#200/205 |
| Per Share | ||
| EPS | $0.25 | US#2,009/3,121 Sec#109/205 |
| BPS | $6.99 | US#2,093/3,121 Sec#123/205 |
Company Info
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.